SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-17-019464
Filing Date
2017-04-06
Accepted
2017-04-06 17:21:12
Documents
3
Group Members
BENJAMIN ROVINSKILUMIRA CAPITAL GP, L.P.LUMIRA CAPITAL II (INTERNATIONAL), L.P.LUMIRA CAPITAL II, L.P.LUMIRA GP HOLDINGS CO.LUMIRA GP INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G v463776_sc13g.htm SC 13G 167574
2 EXHIBIT 1 v463776_ex-1.htm EX-99.1 10363
3 EXHIBIT 2 v463776_ex-2.htm EX-99.2 1626
  Complete submission text file 0001144204-17-019464.txt   181326
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88628 | Film No.: 17746827
SIC: 2834 Pharmaceutical Preparations

Mailing Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5
Business Address 141 ADELAIDE STREET WEST SUITE 770 TORONTO A6 M5H 3L5 416-213-4223
Lumira Capital Investment Management Inc. (Filed by) CIK: 0001702636 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G